Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00382772
Status:
COMPLETED
Last Update Posted:
2016-11-04
First Post:
2006-09-29
Brief Title:
A Study in Infants to Test Two Preparations Freeze-dried or Liquid of the Rotavirus Vaccine HRV Vaccine
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Study to Evaluate Clinical Consistency of the Liquid Formulation of GSK Biologicals HRV Vaccine and to Evaluate Liquid Formulation Compared to Lyophilised Formulation of the HRV Vaccine Administered as a Two-dose Primary Vaccination
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this this study is to evaluate the lot-to-lot consistency of the liquid formulation of GSK Biologicals HRV vaccine and to evaluate the liquid formulation compared to the lyophilised formulation of GSK Biologicals HRV vaccine when administered concomitantly with a combination childhood vaccine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None